Cataract Surgery Devices Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

The cataract surgery devices market covers the full spectrum of equipment used in procedures to replace clouded natural lenses with artificial intraocular lenses (IOLs), including phacoemulsification systems, femtosecond lasers, ophthalmic viscoelastic devices, and related surgical consumables. With a global market value of roughly $10.35 billion in 2025, the industry is experiencing steady expansion supported by increasing surgical volumes and technological innovation. Demand is closely tied to demographics, as cataracts remain the leading cause of vision impairment globally, with prevalence rising sharply after age 60.

• •The market encompasses IOLs (monofocal, multifocal, and toric), phacoemulsification platforms, femtosecond lasers, and surgical consumables
• •Surgical volume is rising annually as cataracts remain the primary cause of treatable vision loss worldwide
• •Technological differentiation is increasingly centered on precision, speed of visual recovery, and reduced surgical trauma

The aging global population is the single most significant factor propelling market growth, as cataract incidence rises substantially with age and life expectancy increases. Broader insurance coverage and greater availability of outpatient surgical centers have expanded access to procedures across both developed and emerging markets. Rising patient expectations for refractive outcomes and independence from glasses continue to drive adoption of premium premium IOLs and advanced phacoemulsification platforms. Additionally, continuous device innovation, particularly in minimally invasive techniques, encourages healthcare facilities to upgrade or expand their surgical capabilities.

• •Growing elderly demographic: Cataract surgery demand rises sharply after age 60 and life expectancy continues to climb
• •Expanded healthcare access: Wider insurance coverage and outpatient surgical infrastructure increase procedure volumes
• •Technology adoption: Femtosecond laser-assisted surgery and premium IOLs with astigmatism and presbyopia correction command higher reimbursement and patient demand

Product segmentation typically includes intraocular lenses (representing the largest revenue share), phacoemulsification devices, femtosecond laser systems, and consumables such as viscoelastic devices and surgical packs. By geography, North America leads the market due to high procedure volumes, favorable reimbursement policies, and rapid adoption of advanced technologies. Europe follows, with strong growth driven by national healthcare systems that fund cataract surgery broadly. The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investment, growing middle-class populations, and a large unmet need given aging demographics in countries such as China, India, and Japan.

• •IOLs dominate product revenue, while femtosecond laser-assisted platforms represent the highest growth segment
• •North America leads globally, supported by Medicare reimbursement and established surgical infrastructure
• •Asia-Pacific is the fastest-expanding region, with China and India driving volume amid rising healthcare spending and large elderly populations

What are the recent trends and outlook?

Femtosecond laser-assisted cataract surgery continues to gain adoption as facilities seek to offer patients greater precision and reduced procedure times. Premium IOLs, such as extended depth-of-focus and trifocal designs, are reshaping competitive dynamics as patients increasingly prioritize spectacle independence. Integration of artificial intelligence and digital connectivity into surgical platforms is expected to enhance pre-operative planning, intra-operative guidance, and patient outcomes. Looking ahead, the market is projected to sustain a compound annual growth rate near 4.76%, supported by global demographic trends, expanding surgical capacity in emerging economies, and ongoing product innovation.

• •Femtosecond laser adoption is increasing as patients demand greater procedural precision and faster recovery
• •Premium IOL demand is accelerating as reimbursement evolves and patients seek reduced dependency on glasses post-surgery
• •Digital integration, including AI-assisted planning and connectivity, is becoming a distinguishing feature in next-generation surgical platforms